Azilsartan: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
=== | ===[[Azilsartan kamedoxomil|Azilsartan Kamedoxomil (Edarbi)]]=== | ||
===[[Azilsartan Kamedoxomil and Chlorthalidone|Azilsartan Kamedoxomil and Chlorthalidone (Edarbyclor)]]=== | |||
=== | |||
==Overview== | ==Overview== | ||
Revision as of 05:30, 22 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Azilsartan Kamedoxomil (Edarbi)
Azilsartan Kamedoxomil and Chlorthalidone (Edarbyclor)
Overview
Azilsartan is a selective AT1 subtype angiotensin II receptor antagonist used in treatment of hypertension to lower blood pressure. Common adverse reactions include hypotension/orthostatic hypotension.
Category
Angiotensin 2 Receptor Blocker